Nextgen Biomed Management
Management criteria checks 0/4
Nextgen Biomed's CEO is Harel Hershtik, appointed in Nov 2022, has a tenure of 1.42 years. directly owns 5.67% of the company’s shares, worth ₪438.24K. The average tenure of the management team and the board of directors is 1.4 years and 1.4 years respectively.
Key information
Harel Hershtik
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.4yrs |
| CEO ownership | 5.7% |
| Management average tenure | 1.4yrs |
| Board average tenure | 1.4yrs |
CEO
Harel Hershtik (48 yo)
1.4yrs
Tenure
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & GM | 1.4yrs | no data | 5.67% ₪ 438.2k | |
| CFO & VP of Finance | 1.3yrs | no data | no data | |
| Legal Advisor & Company Secretary | 9.3yrs | ₪195.00k | no data |
1.4yrs
Average Tenure
Experienced Management: NXGN's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent External Director | 1.3yrs | no data | no data | |
| Chairman of the Board | 3.3yrs | ₪289.00k | 1.31% ₪ 101.0k | |
| Independent External Director | 1.3yrs | no data | no data | |
| Director | 1.4yrs | no data | no data | |
| Director | 1.4yrs | no data | no data | |
| Director | 1.3yrs | no data | no data |
1.4yrs
Average Tenure
55yo
Average Age
Experienced Board: NXGN's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.